Global Burden Of Disease Studies: Implications For Mental And Substance Use Disorders
Author(s) -
Harvey Whiteford,
Alize J Ferrari,
Louisa Degenhardt
Publication year - 2016
Publication title -
health affairs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.837
H-Index - 178
eISSN - 2694-233X
pISSN - 0278-2715
DOI - 10.1377/hlthaff.2016.0082
Subject(s) - burden of disease , disease burden , psychological intervention , mental health , global health , environmental health , medicine , disease , epidemiology , health policy , economic cost , psychiatry , substance use , action (physics) , public health , public economics , gerontology , population , economics , nursing , physics , neoclassical economics , pathology , quantum mechanics
Global Burden of Disease studies have highlighted mental and substance use disorders as the leading cause of disability globally. Using the studies' findings for policy and planning requires an understanding of how estimates are generated, the required epidemiological data are gathered, disability and premature mortality are defined and counted, and comparative risk assessment for risk-factor analysis is undertaken. The high burden of mental and substance use disorders has increased their priority on the global health agenda, but not enough to prompt concerted action by governments and international agencies. Using Global Burden of Disease estimates in health policy and planning requires combining them with other information such as evidence on the cost-effectiveness of interventions designed to reduce the disorders' burden. Concerted action is required by mental health advocates and policy makers to assemble this evidence, taking into account the health, social, and economic challenges facing each country.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom